Toronto Dominion Bank Sells 1,729 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Toronto Dominion Bank decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 20,014 shares of the exchange traded fund’s stock after selling 1,729 shares during the period. Toronto Dominion Bank’s holdings in SPDR S&P Biotech ETF were worth $1,977,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at about $141,284,000. Affinity Asset Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 105.4% in the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after buying an additional 737,550 shares during the last quarter. Mirae Asset Securities USA Inc. bought a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth about $55,626,000. Finally, Assetmark Inc. increased its position in SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of XBI stock opened at $93.40 on Monday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm’s 50 day moving average is $98.05 and its 200-day moving average is $97.13. The firm has a market capitalization of $7.12 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.